Celularity Inc — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| LeVien Vincent | — | Award / Grant | 125,000 | — | — | 125,000 | Dec 29, 2025 |
| Ling Geoffrey M.D. | — | Award / Grant | 125,000 | — | — | 236,795 | Dec 29, 2025 |
| Parks Diane L. | — | Award / Grant | 125,000 | — | — | 490,021 | Dec 29, 2025 |
| Diamandis Peter | — | Award / Grant | 125,000 | — | — | 373,765 | Dec 29, 2025 |
| Parks Diane L. | — | Award / Grant | 67,416 | — | — | 365,021 | Dec 19, 2025 |
| Ling Geoffrey M.D. | — | Award / Grant | 67,416 | — | — | 111,795 | Dec 19, 2025 |
| Diamandis Peter | — | Award / Grant | 67,416 | — | — | 248,765 | Dec 19, 2025 |
| Parks Diane L. | — | Award / Grant | 61,539 | — | — | 365,021 | Nov 19, 2025 |
| LeVien Vincent | — | Award / Grant | 3,699 | — | — | 3,699 | Nov 19, 2025 |
| Ling Geoffrey M.D. | — | Award / Grant | 44,379 | — | — | 111,795 | Nov 19, 2025 |
| Diamandis Peter | — | Award / Grant | 47,042 | — | — | 248,765 | Nov 19, 2025 |
| Hariri Robert J | Chief Executive Officer | Option Exercise | 3,281 | — | — | 2,852,608 | Apr 13, 2025 |
| Beers David C | Chief Financial Officer | Tax Withholding | 360 | $1.64 | $590 | 18,201 | Apr 13, 2025 |
| Hariri Robert J | Chief Executive Officer | Option Exercise | 3,281 | — | — | 21,482 | Apr 13, 2025 |
| Haines John R | Senior Exec Vice President | Option Exercise | 1,641 | — | — | 29,698 | Apr 13, 2025 |
| Brigido Stephen | Pres., Functional Regeneration | Option Exercise | 820 | — | — | 9,189 | Apr 13, 2025 |
| Brigido Stephen | Pres., Functional Regeneration | Option Exercise | 10,000 | — | — | 11,641 | Feb 17, 2025 |
| Beers David C | Chief Financial Officer | Option Exercise | 12,500 | — | — | 21,932 | Feb 17, 2025 |
| Haines John R | Senior Exec Vice President | Option Exercise | 20,000 | — | — | 35,092 | Feb 17, 2025 |
| Genting Berhad | — | X | 652,981 | $2.07 | $1,351,671 | 6,335,630 | Jan 24, 2025 |
| Diamandis Peter | — | Award / Grant | 67,416 | — | — | 201,723 | Dec 19, 2024 |
| Parks Diane L. | — | Award / Grant | 67,416 | — | — | 303,482 | Dec 19, 2024 |
| Ling Geoffrey M.D. | — | Award / Grant | 67,416 | — | — | 67,416 | Dec 19, 2024 |
| BERMAN RICHARD J | — | Award / Grant | 67,416 | — | — | 67,416 | Dec 19, 2024 |
| Kehler Dean C | — | Award / Grant | 67,416 | — | — | 303,482 | Dec 19, 2024 |
| Diamandis Peter | — | Award / Grant | 67,416 | — | — | 1,374,482 | Dec 19, 2024 |
| Hariri Robert J | Chief Executive Officer | Tax Withholding | 1,154 | $4.11 | $4,743 | 2,855,889 | Apr 13, 2024 |
| Fletcher Kyle | See Remarks | Tax Withholding | 20 | $4.11 | $82 | 21,085 | Apr 13, 2024 |
| Haines John R | See Remarks | Tax Withholding | 576 | $4.11 | $2,367 | 38,373 | Apr 13, 2024 |
| Beers David C | Chief Financial Officer | Tax Withholding | 360 | $4.11 | $1,480 | 23,983 | Apr 13, 2024 |
| Brigido Stephen | Pres, Functional Regeneration | Tax Withholding | 268 | $4.11 | $1,101 | 19,472 | Apr 13, 2024 |
| Fletcher Kyle | See Remarks | Tax Withholding | 617 | $5.68 | $3,505 | 21,105 | Mar 15, 2024 |
| Kilcoyne Adrian | Chief Medical Officer | Tax Withholding | 52,762 | $0.43 | $22,688 | 1,122,238 | Feb 17, 2024 |
| Haines John R | See Remarks | Tax Withholding | 70,350 | $0.43 | $30,251 | 389,497 | Feb 17, 2024 |
| Beers David C | Chief Financial Officer | Tax Withholding | 43,968 | $0.43 | $18,906 | 243,437 | Feb 17, 2024 |
| Brigido Stephen | Pres, Functional Regeneration | Tax Withholding | 32,720 | $0.43 | $14,070 | 197,406 | Feb 17, 2024 |
| Fletcher Kyle | See Remarks | Tax Withholding | 39,571 | $0.43 | $17,016 | 217,228 | Feb 17, 2024 |
| Genting Berhad | — | Purchase | 21,410,983 | $0.25 | $5,352,746 | 51,473,762 | Jan 12, 2024 |
| Sorrento Therapeutics, Inc. | — | Sale | 9,064,539 | — | — | 11,357,585 | Oct 5, 2023 |
| Hariri Robert J | Chief Executive Officer | Purchase | 6,307,158 | $0.16 | $1,009,145 | 25,520,007 | Sep 29, 2023 |
| Kilcoyne Adrian | Chief Medical Officer | Award / Grant | 875,000 | — | — | 1,175,000 | Jul 14, 2023 |
| Lim Kok Thay | — | Tax Withholding | 10,844 | $0.75 | $8,133 | 225,222 | Jun 14, 2023 |
| Parks Diane L. | — | Award / Grant | 199,921 | — | — | 236,066 | Jun 14, 2023 |
| Kehler Dean C | — | Award / Grant | 199,921 | — | — | 236,066 | Jun 14, 2023 |
| Smith Robin L | — | Award / Grant | 199,921 | — | — | 236,066 | Jun 14, 2023 |
| Mazur Marc | — | Award / Grant | 199,921 | — | — | 236,066 | Jun 14, 2023 |
| VON ESCHENBACH ANDREW C. | — | Award / Grant | 199,921 | — | — | 336,066 | Jun 14, 2023 |
| SCULLEY JOHN | — | Award / Grant | 199,921 | — | — | 1,004,660 | Jun 14, 2023 |
| Diamandis Peter | — | Award / Grant | 199,921 | — | — | 1,307,066 | Jun 14, 2023 |
| Lim Kok Thay | — | Award / Grant | 199,921 | — | — | 236,066 | Jun 14, 2023 |